However, his seizures stopped completely when THC was added to his treatment; from seizures each month, after trying all possible drugs, to zero seizures on CBD and THC.
Other studies considering children with epilepsy, albeit small scale or observational, have also found benefit from a small amount of THC in the CBD full-extract product [6] , [7]. Still, the BPNA said that more evidence is needed. It also suggested that THC can damage developing brains [8] , despite a lack of published evidence to support this. Probably not. What else prevents prescription? Another good reason is that some doctors are ignorant about the benefits of cannabis, which is understandable.
Many were not taught about cannabis in a treatment context in medical school, and they may have a poor understanding of the endocannabinoid system. I would not want my doctor to prescribe something about which they knew very little — especially if they had no idea what dose, type or form of cannabis to recommend.
For these reasons, education is extremely important, and it has to start somewhere. We need only a core of around doctors trained in the medical benefits of cannabis products, and how to prescribe them, to work alongside other health professionals in regional centres to start normalising cannabis prescriptions.
Another, similarly justified, reason for a lack of cannabis prescriptions is that the vast majority of medical cannabis products are unlicensed only one product — Sativex — is licensed, but it has a very restricted label. This means that the prescriber has to take full responsibility for the prescription and is in the firing line for legal action if something goes wrong.
I am not a lawyer, but it seems to me that if a prescriber weighs up the evidence, takes into account the guidelines and acts in the best interest of the patient, successful action against the prescriber seems unlikely. Medical cannabis is remarkably safe with very few contraindications, but if you know the contraindications and prescribe sensibly, all should be well. The UK supply chain poses a logistical barrier to prescriptions, too. In Callaghan v. Darlington Fabrics Corp. A registered qualifying patient may not be considered to be under the influence of cannabis solely because of the presence of metabolites or components of cannabis that appear in insufficient concentration to cause impairment.
Registered healthcare providers and patients are protected from criminal and civil liability, provided they comply with the law. In , the Washington State Supreme Court ruled in favor of an employer who was sued after terminating a medical marijuana patient Roe v. Teletech Customer Care Management. The law also limits when parental rights and residential time can be limited due to the medical use of marijuana.
NOTE: This is not intended for or offered as legal advice. It is for informational and educational purposes only. Alaska None known. Arkansas None known. California In Ross v. Illinois None known.
Maryland None known. Massachusetts In Barbuto v. Missouri None known. Montana The Montana Supreme Court upheld the dismissal of a patient who tested positive for marijuana metabolites in Johnson v. Oklahoma None known. Rhode Island In Callaghan v. Vermont None known. The patient and caregiver protections in the medical marijuana law are from criminal penalties.
West Virginia None known. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer Chemother Pharmacol. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review.
Opioids out, cannabis in: Negotiating the unknowns in patient care for chronic pain. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Fam Pract. An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol.
Front Pharmacol. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. Association between marijuana use and risk of cancer: a systematic review and meta-analysis.
Cannabis use and car crashes: A review. Front Psychiatry. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials. Can Fam Physician. Cannabis and pain: a clinical review.
Cannabis Cannabinoid Res. Maida V, Daeninck PJ. A user's guide to cannabinoid therapies in oncology. Curr Oncol. Associations between cannabis use and physical health problems in early midlife: A longitudinal comparison of persistent cannabis vs tobacco users.
JAMA Psychiatry. Your Privacy Rights. Development of drugs from botanicals such as the marijuana plant poses numerous challenges. Botanicals may contain hundreds of unknown, active chemicals, and it can be difficult to develop a product with accurate and consistent doses of these chemicals. Use of marijuana as medicine also poses other problems such as the adverse health effects of smoking and THC-induced cognitive impairment. Nevertheless, a growing number of states have legalized dispensing of marijuana or its extracts to people with a range of medical conditions.
Further research will be needed to determine whether people whose health has been compromised by disease or its treatment e. A new study underscores the need for additional research on the effect of medical marijuana laws on opioid overdose deaths and cautions against drawing a causal connection between the two.
Early research suggested that there may be a relationship between the availability of medical marijuana and opioid analgesic overdose mortality.
0コメント